Next Article in Journal
Glycan-Modified Apoptotic Melanoma-Derived Extracellular Vesicles as Antigen Source for Anti-Tumor Vaccination
Next Article in Special Issue
Kinase Inhibitors and Ovarian Cancer
Previous Article in Journal
Current Status of Gene Therapy in Hepatocellular Carcinoma
Previous Article in Special Issue
Cancer Cell Lines Are Useful Model Systems for Medical Research
Open AccessArticle

Glycolipids Recognized by A2B5 Antibody Promote Proliferation, Migration, and Clonogenicity in Glioblastoma Cells

1
Aix Marseille University, CNRS, INP, Inst Neurophysiopathol, Marseille, France
2
Service d’Anatomie Pathologique et de Neuropathologie, Hôpital de la Timone, AP-HM, Marseille, France
*
Author to whom correspondence should be addressed.
These authors contributed equally to the research.
Cancers 2019, 11(9), 1267; https://doi.org/10.3390/cancers11091267
Received: 17 July 2019 / Revised: 20 August 2019 / Accepted: 24 August 2019 / Published: 28 August 2019
(This article belongs to the Special Issue Targeting Solid Tumors)
A2B5+ cells isolated from human glioblastomas exhibit cancer stem cell properties. The A2B5 epitope belongs to the sialoganglioside family and is synthetized by the ST8 alpha-N-acetyl-neuraminidase α-2,8-sialyltransferase 3 (ST8SIA3) enzyme. Glycolipids represent attractive targets for solid tumors; therefore, the aim of this study was to decipher A2B5 function in glioblastomas. To this end, we developed cell lines expressing various levels of A2B5 either by genetically manipulating ST8SIA3 or by using neuraminidase. The overexpression of ST8SIA3 in low-A2B5-expressing cells resulted in a dramatic increase of A2B5 immunoreactivity. ST8SIA3 overexpression increased cell proliferation, migration, and clonogenicity in vitro and tumor growth when cells were intracranially grafted. Conversely, lentiviral ST8SIA3 inactivation in low-A2B5-expressing cells resulted in reduced proliferation, migration, and clonogenicity in vitro and extended mouse survival. Furthermore, in the shST8SIA3 cells, we found an active apoptotic phenotype. In high-A2B5-expressing cancer stem cells, lentiviral delivery of shST8SIA3 stopped cell growth. Neuraminidase treatment, which modifies the A2B5 epitope, impaired cell survival, proliferation, self-renewal, and migration. Our findings prove the crucial role of the A2B5 epitope in the promotion of proliferation, migration, clonogenicity, and tumorigenesis, pointing at A2B5 as an attractive therapeutic target for glioblastomas. View Full-Text
Keywords: A2B5; ST8SIA3; glioblastoma; cancer stem cell; tumorigenicity A2B5; ST8SIA3; glioblastoma; cancer stem cell; tumorigenicity
Show Figures

Figure 1

MDPI and ACS Style

Baeza-Kallee, N.; Bergès, R.; Soubéran, A.; Colin, C.; Denicolaï, E.; Appay, R.; Tchoghandjian, A.; Figarella-Branger, D. Glycolipids Recognized by A2B5 Antibody Promote Proliferation, Migration, and Clonogenicity in Glioblastoma Cells. Cancers 2019, 11, 1267.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop